Recent Potential Treatment Approaches for the Management of Uveitis

Uveitis is an infl ammatory disease affecting the uveal tract of the eye. Non-infectious uveitis [NIU] is known to be the main cause of blindness in people of all age groups in different parts of the world. NIU can be both due to autoimmune or idiopathic responses causing severe vision-related complications leading to irreversible vision loss. Thus, the treatment of this disease after the rapid diagnosis and evaluation by eminent ophthalmologists and rheumatologists is very important. The primary goal of treatment of uveitis is to limit the infl ammation process and prevent recurring responses and hence preserving the vision. The current treatment therapies include corticosteroids as fi rst-line agents followed by more potent drugs including synthetic immunosuppressants like calcineurin inhibitors, antimetabolites, and alkylating agents. However, some patients are reported to be intolerant to these therapies, therefore, biologic agents are adopted as an effective treatment approach in such cases. Anti TNF-α agents have shown promising results in the treatment process. This review enlightens about the current effective treatment approaches that are adopted as potential therapeutic agents preventing NIU. Short Communication Recent Potential Treatment Approaches for the Management of Uveitis Nikita1 and Yasmin Sultana2* 1Department of Pharmaceutics, School of Pharmaceutical Education & Research, Jamia Hamdard,